The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 119:984-985, April 1963
doi: 10.1176/appi.ajp.119.10.984
© 1963 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by BAN, T. A.
* Articles by LEHMANN, H. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by BAN, T. A.
* Articles by LEHMANN, H. E.

THE EFFECT OF CLOPENTHIXOL ON CHRONIC PSYCHIATRIC PATIENTS

T. A. BAN M.D., K. FERGUSON M.D., , and H. E. LEHMANN M.D.1

1 Verdun Protestant Hospital, 6875 LaSalle Blvd., Verdun, Quebec.

In our clinical trial with 20 male chronic patients on a mental hospital ward, clopenthixol appeared to have observable antipsychotic properties with relatively little toxicity. The observation that this drug was therapeutically effective in certain chronic sohizaphrenic patients where previous treatments had failed is in accordance with the findings of other clinical investigators and suggests that clopenthixol may deserve a place among the clinically used antipsychotic compounds.







Get information about faster international access.

Privacy Policy

Copyright © 1963 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org